Aptadir Therapeutics
Aptadir Therapeutics is developing a treatment for Myelodysplastic Neoplasms based on the capability of specific RNA therapeutics.
$45M Seed ·
Source: entarabi.com
Funding history ↓Signals
Website registeredFeb 13, 2024 (2 years old)
Funding rounds
| Date | Round | Amount | Lead | Source |
|---|---|---|---|---|
| Seed | $45M | — | entarabi.com |
Timeline
- Website created
Founders and team
AD
Annalisa Di Ruscio FounderDG
Daniel G. Tenen FounderMK
Marcin Kortylewski FounderVD
Vittorio de Franciscis FounderGA
Giovanni Amabile CEO & Executive Chairman
Investors
44BIO Capital
AAngelini Ventures
CCDP Venture Capital
CClub degli Investitori
CCrescent Enterprises
EEvotec
EExtend
IIndaco Venture Partners
IItalian Angels for Biotech
KKerna Ventures
XXGEN Venture
Companies like Aptadir Therapeutics
MMerida Biosciences$120M Series A · May 2025
RReCode TherapeuticsSeries B+ · Oct 2023GGlycoEra$130M Series B+ · May 2025
EExcalipoint TherapeticsSeed · Mar 2026
GGrannus Therapeutics
LLatus Bio$97M Series A · May 2026
Sources and API
Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/aptadir-therapeutics (get a free API key).